<p class="abstract"><strong>Background:</strong> To evaluate the effects of platelet-rich plasma (PRP) infiltration in patients with lateral epicondylitis of the elbow.</p><p class="abstract"><strong>Methods:</strong> A randomized, prospective study on 60 patients with lateral epicondylitis of the elbow was conducted at Ruby Hall Clinic, Pune. The patients were randomized and evaluated after receiving infiltration of three milliliters of PRP, or methyl prednisolone. The base-line evaluation was done using visual analog score (VAS) and modified Mayo performance index for elbow (MAYO). Re-evaluation was after 1 and 6 months of the procedure. Statistical analysis was done using independent t-test.<strong></strong></p><p class="abstract"><strong>Results:</strong> After 6 months of treatment with PRP, patients with lateral epicondylitis had a statistically significant improvement in their VAS (p<0.05) in contrast to steroid. However, no statistical difference in modified Mayo performance index was found between the two groups at 1 and 6 months after intervention.</p><p><strong>Conclusions:</strong> Treatment of patients with lateral epicondylitis with PRP reduces pain and is better tolerated than steroid therapy. Thus, the novel PRP therapy can be considered as a primary approach to treat patients of lateral epicondylitis conservatively. </p>
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.